Back to search

The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden

Data up to Jan 2025

Published1997
Citations206
References35

Total Citations Per Year

Abstract

References (35)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

The Statistical Analysis of Failure Time Data.

1981 • 10,224 citations

Mutation in blood coagulation factor V associated with resistance to activated protein C

1994 • 3,871 citations

Value of the Ventilation/Perfusion Scan in Acute Pulmonary Embolism

1990 • 2,702 citations

Antithrombotic Therapy for Venous Thromboembolic Disease

2001 • 2,108 citations

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1996 • 2,090 citations

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

1993 • 1,997 citations

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study

1991 • 1,994 citations

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

1996 • 1,331 citations

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1993 • 1,283 citations

Hemorrhagic Complications of Anticoagulant Treatment

2001 • 1,170 citations

Resistance to Activated Protein C as a Basis for Venous Thrombosis

1994 • 1,148 citations

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1996 • 1,088 citations

Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis

1996 • 1,034 citations

A prospective study of the incidence of deep‐vein thrombosis within a defined urban population

1992 • 799 citations

Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis

1982 • 753 citations

The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin

1996 • 559 citations

Value of the ventilation/perfusion scan in acute pulmonary embolism

1990 • 493 citations

Deficiencies of Coagulation-Inhibiting and Fibrinolytic Proteins in Outpatients with Deep-Vein Thrombosis

1990 • 456 citations

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

1994 • 446 citations

Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis

1982 • 445 citations

Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]

1993 • 411 citations

Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis

1995 • 364 citations

Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]

1993 • 337 citations

Hemorrhagic Complications of Anticoagulant Therapy

1974 • 310 citations

Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism

1995 • 307 citations

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism

1995 • 251 citations

The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects

1994 • 170 citations

Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.

1992 • 151 citations

Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia

1994 • 129 citations

Probability of Recurrence of Thrombosis in Patients with and without Factor V Leiden

1996 • 92 citations

Duration of Oral Anticoagulant Therapy after Proximal Deep Vein Thrombosis: a Decision Analysis

1994 • 43 citations

Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs

1996 • 29 citations

Effect of Inhaled Furosemide on the Bronchial Response to Lysine-Aspirin Inhalation in Asthmatic Subjects

1992 • 27 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden (1997) – Thrombosis and Haemostasis | Metascience Observatory Explorer